Skip to main content
OpenTrials

Clinical trial condition

Hemostatic Disorders

Explore clinical trials studying Hemostatic Disorders. Study availability and eligibility vary by location and protocol.

3,075 public trials 581 recruiting studies
Refine in advanced search Browse all conditions

Hemostatic Disorders trial results

Completed

Aurora A Kinase Inhibitor MLN8237 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma

NCT01034553

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • University of California, San Francisco San Francisco, California, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Completed

Bendamustine, Bortezomib (Velcade ®) and Prednisone (BVP) in Patients Newly Diagnosed Multiple Myeloma

NCT01376401

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Hospital Germans Trias i Pujol Badalona, Barcelona, Spain
  • Hospital Clínic Barcelona, Spain
  • Institut català d'Oncología Barcelona, Spain
  • Hospital 12 de Octubre Madrid, Spain
View all 14 locations
View Trial Details
Completed

Melphalan, Prednisone, Thalidomide and Defibrotide in Relapsed Multiple Myeloma Patients

NCT00406978

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Dip. Scienze Mediche & IRCAD-Università, UDA Ematologia Novara, Italy
  • Policlinico Monteluce, Clinica Medica I Perugia, Italy
  • Divisione Di Ematologia, Ospedali Riuniti Reggio Calabria, Italy
  • Servizio di Ematologia, Azienda Ospedaliera S. Maria Nuova Reggio Emilia, Italy
View Trial Details

Related conditions